Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Exercise  COVID-19 treatment studies for Exercise  C19 studies: Exercise  Exercise   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Recovery time 66% Improvement Relative Risk Dyspnea after hospitalizat.. 67% c19early.com/ex Kontopoulou et al. Exercise for COVID-19 Prophylaxis Favors exercise Favors inactivity
Kontopoulou, 66 patient exercise study: 66% faster recovery [p<0.0001] https://c19p.org/kontopoulou
copied to clipboard
Exercise Preferences and Benefits in Patients Hospitalized with COVID-19
Kontopoulou et al., Journal of Personalized Medicine, doi:10.3390/jpm12040645
17 Apr 2022    Source   PDF   Share   Tweet
Retrospective 66 hospitalized COVID-19 patients in Greece, showing significantly improved recovery with a history of exercise in unadjusted results. Exercise after hospitalization was also associated with lower levels of dyspnea one month post hospitalization.
recovery time, 66.2% lower, relative time 0.34, p < 0.001, high activity levels mean 22.0 (±14.0) n=42, low activity levels mean 65.0 (±32.0) n=24.
relative dyspnea after hospitalization, 66.7% better, RR 0.33, p < 0.001, high activity levels mean 1.0 (±1.0) n=42, low activity levels mean 3.0 (±1.0) n=24, inverted to make RR<1 favor high activity levels.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
Kontopoulou et al., 17 Apr 2022, retrospective, Greece, peer-reviewed, survey, 4 authors, study period November 2020 - December 2020.
Contact: raniakotsiou@gmail.com (corresponding author), sevi_kon@hotmail.com, zdaniil@uth.gr, kgourg@med.uth.gr.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperExerciseAll
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit